Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 3
1998 1
1999 2
2000 2
2001 4
2002 7
2003 7
2004 9
2005 16
2006 6
2007 8
2008 22
2009 13
2010 22
2011 29
2012 32
2013 27
2014 15
2015 42
2016 49
2017 51
2018 45
2019 35
2020 16
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25904755

402 results
Results by year
Filters applied: . Clear all
Page 1
A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM).
Wetmore JB, Gurevich K, Sprague S, Da Roza G, Buerkert J, Reiner M, Goodman W, Cooper K. Wetmore JB, et al. Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1031-40. doi: 10.2215/CJN.07050714. Epub 2015 Apr 22. Clin J Am Soc Nephrol. 2015. PMID: 25904755 Free PMC article. Clinical Trial.
Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Sprague SM, Wetmore JB, Gurevich K, Da Roza G, Buerkert J, Reiner M, Goodman W, Cooper K. Sprague SM, et al. Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1021-30. doi: 10.2215/CJN.03270314. Epub 2015 Apr 14. Clin J Am Soc Nephrol. 2015. PMID: 25873267 Free PMC article. Clinical Trial.
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Block GA, Bushinsky DA, Cheng S, Cunningham J, Dehmel B, Drueke TB, Ketteler M, Kewalramani R, Martin KJ, Moe SM, Patel UD, Silver J, Sun Y, Wang H, Chertow GM. Block GA, et al. JAMA. 2017 Jan 10;317(2):156-164. doi: 10.1001/jama.2016.19468. JAMA. 2017. PMID: 28097356 Free article. Clinical Trial.
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, Port FK, Pisoni RL, Robinson BM. Tentori F, et al. Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16. Clin J Am Soc Nephrol. 2015. PMID: 25516917 Free PMC article.
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism.
Messa P, Macário F, Yaqoob M, Bouman K, Braun J, von Albertini B, Brink H, Maduell F, Graf H, Frazão JM, Bos WJ, Torregrosa V, Saha H, Reichel H, Wilkie M, Zani VJ, Molemans B, Carter D, Locatelli F. Messa P, et al. Clin J Am Soc Nephrol. 2008 Jan;3(1):36-45. doi: 10.2215/CJN.03591006. Clin J Am Soc Nephrol. 2008. PMID: 18178780 Free PMC article. Clinical Trial.
Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients.
Cooper K, Quarles D, Kubo Y, Tomlin H, Goodman W. Cooper K, et al. Nephron Clin Pract. 2012;121(3-4):c124-30. doi: 10.1159/000345164. Epub 2012 Nov 29. Nephron Clin Pract. 2012. PMID: 23208191 Clinical Trial.
Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism.
Yamada S, Tokumoto M, Taniguchi M, Toyonaga J, Suehiro T, Eriguchi R, Fujimi S, Ooboshi H, Kitazono T, Tsuruya K. Yamada S, et al. Ther Apher Dial. 2015 Aug;19(4):367-77. doi: 10.1111/1744-9987.12292. Epub 2015 Apr 7. Ther Apher Dial. 2015. PMID: 25851690 Clinical Trial.
Cinacalcet for managing secondary hyperparathyroidism in dialysis patients in clinical practice in Belgium: a 16-month observational study (ECHO-B).
Debelle F, Meeus G, Dratwa M, Maes B, Vanholder R, Albert A, Schutyser E, Jadoul M. Debelle F, et al. Acta Clin Belg. 2013 Jul-Aug;68(4):275-81. doi: 10.2143/ACB.3231. Acta Clin Belg. 2013. PMID: 24455797
Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis.
Mei C, Chen N, Ding X, Yu X, Wang L, Qian J, Wang M, Jiang G, Li X, Hou F, Zuo L, Wang N, Liu H. Mei C, et al. Hemodial Int. 2016 Oct;20(4):589-600. doi: 10.1111/hdi.12410. Epub 2016 Mar 4. Hemodial Int. 2016. PMID: 26940692 Clinical Trial.
Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006.
St Peter WL, Li Q, Liu J, Persky M, Nieman K, Arko C, Block GA. St Peter WL, et al. Clin J Am Soc Nephrol. 2009 Feb;4(2):354-60. doi: 10.2215/CJN.05241008. Epub 2009 Jan 7. Clin J Am Soc Nephrol. 2009. PMID: 19129318 Free PMC article.
402 results
Jump to page
Feedback